North America Obesity Treatment Market

Published Apr 01, 2025

Length 350 Pages

SKU # DAABD20406821

Description

North America obesity treatment market is expected to reach USD 68,985.14 thousand by 2032 from USD 22,757.18 thousand in 2024, growing at a CAGR of 14.9% in the forecast period of 2025 to 2032.
Market Segmentation:
North America Obesity Treatment Market, Treatment Type (Pharmacological Treatments (Anti-obesity Drugs), Bariatric Surgery, Behavioral & Lifestyle Therapy, Non-Invasive/ Endoscopic Procedures, and Medical Devices & Technologies), Age Group (Adult Obesity Treatment, Geriatric Obesity Treatment, and Pediatric Obesity Treatment), Distribution Channel (Online Pharmacies, Retail Pharmacies, Weight Management Clinics, Hospital Pharmacies, and Wellness & Fitness Centers), Patient Type (Class III, Class II, and Class I), Country (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2032

Overview of North America Obesity Treatment market Dynamics:

Driver

• Integration of Digital Health Solutions in Obesity Treatment

Restraint

• Anti-Obesity Drugs and Surgical Interventions Carry Risks

Opportunity

• Increasing Prevalence of Lifestyle Related Diseases

Market Players:

The key market players operating in the North America obesity treatment market are listed below:

• Novo Nordisk A/S
• Eli Lilly and Company
• Medtronic Plc.
• Boston Scientific Corporation
• Johnson & Johnson Services, Inc.
• AstraZeneca
• Sanofi
• Allurion Technologies
• Reshape Lifesciences
• Currax Pharmaceuticals LLC
• Arena Pharmaceuticals Ltd
• VIVUS LLC.
• Noom, Inc.
• Omada Health Inc
• USGI Medical
• GSK plc
• Morphic Medical, Inc.
• Altimmune.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The North America Obesity Treatment Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Multivariate Modelling; 2.6 Treatment Type Lifeline Curve; 2.7 Primary Interviews With Key Opinion Leaders; 2.8 Dbmr Market Position Grid; 2.9 Market End User Coverage Grid; 2.10 Vendor Share Analysis; 2.11 Secondary Sources; 2.12 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Porter’s Five Forces; 4.2 Pestel Analysis; 4.3 Epidemiology: North America Obesity Treatment Market; 4.4 Drug Treatment Rate By Matured Markets: North America Obesity Treatment Market; 4.5 Drug; 4.6 Word Pipeline
5 Regulatory Framework For The North America Obesity Treatment Market: 5.1 Regulatory Approval Pathways; 5.2 Licensing And Registration; 5.3 Regulatory Approval Pathways; 5.4 Licensing And Registration; 5.5 Good Manufacturing Practices (Gmps) Guidelines
6 Market Overview: 6.1 Drivers; 6.1.1 Increasing Prevalence Of Obesity; 6.1.2 Innovations In Anti-obesity Medications; 6.1.3 Growth In Bariatric And Metabolic Surgeries.; 6.1.4 Integration Of Digital Health Solutions In Obesity Treatment; 6.2 Restraints; 6.2.1 Anti-obesity Drugs And Surgical Interventions Carry Risks; 6.2.2 High Relapse Rates Post-treatment Of Obesity; 6.3 Opportunities; 6.3.1 Increasing Prevalence Of Lifestyle Related Diseases; 6.3.2 Rising Disposable Income Enhancing The Purchasing Power For Obesity Treatment Related Products; 6.3.3 Rise In Strategic Initiatives And Launches By Market Players; 6.4 Challenges; 6.4.1 Long-term Follow-ups Associated With Obesity Treatment; 6.4.2 Addressal Of The Lifestyle And Behavioral Changes
7 North America Obesity Treatment Market, By Treatment Type: 7.1 Overview; 7.2 Pharmacological Treatments (Anti-obesity Drugs); 7.2.1 Glp-1 Receptor Agonists; 7.2.2 Dual Gip/ Glp-1 Receptor Agonists; 7.2.2.1 Phentermine; 7.2.2.2 Phentermine-topiramate; 7.2.2.3 Naltrexone-bupropion; 7.2.3 Lipase Inhibitors; 7.2.4 Deoxycholic Acid; 7.2.5 Others; 7.3 Bariatric Surgery; 7.3.1 Restrictive Surgeries; 7.3.1.1 Sleeve Gastrectomy; 7.3.1.2 Adjustable Gastric Banding; 7.3.2 Combination Surgeries; 7.3.2.1 Roux-en-y Gastric Bypass (Rygb); 7.3.2.2 Mini-gastric Bypass (Mgb); 7.3.3 Malabsorptive Surgeries; 7.3.3.1 Laparoscopic Surgery; 7.3.3.2 Robotic-assisted Surgery; 7.3.3.3 Open Surgery; 7.4 Behavioral & Lifestyle Therapy; 7.4.1 Dietary Interventions; 7.4.2 Behavioral Modification Therapy; 7.4.3 Physical Activity Programs; 7.4.4 Psychological Counseling; 7.5 Non-invasive/ Endoscopic Procedures; 7.5.1 Endoscopic Sleeve Gastroplasty (Esg); 7.5.2 Intragastric Balloon (Igb); 7.5.2.1 Orbera Intragastric Balloon; 7.5.2.2 Spatz Adjustable Balloon System; 7.5.3 Aspiration Therapy (Aspireassist); 7.5.4 Transoral Gastroplasty (Toga); 7.6 Medical Devices & Technologies; 7.6.1 Artificial Intelligence & Digital Weight Management Platforms; 7.6.2 Gastric Electrical Stimulation Devices (Maestro System)
8 North America Obesity Treatment Market, By Age Group: 8.1 Overview; 8.2 Adult Obesity Treatment; 8.3 Geriatric Obesity Treatment; 8.4 Pediatric Obesity Treatment
9 North America Obesity Treatment Market, By Distribution Channel: 9.1 Overview; 9.2 Online Pharmacies; 9.3 Retail Pharmacies; 9.4 Weight Management Clinics; 9.5 Hospital Pharmacies; 9.6 Wellness & Fitness Centers
10 North America Obesity Treatment Market, By Patient Type: 10.1 Overview; 10.2 Class Iii; 10.3 Class Ii; 10.4 Class I
11 North America Obesity Treatment Market, By Region: 11.1 North America; 11.1.1 U.S.; 11.1.2 Mexico; 11.1.3 Canada
12 North America Obesity Treatment Market, Company Landscape: 12.1 Company Share Analysis: North America
13 Swot Analysis
14 Company Profile: 14.1 Novo Nordisk A/S; 14.1.1 Company Snapshot; 14.1.2 Revenue Analysis; 14.1.3 Company Share Analysis; 14.1.4 Product Portfolio; 14.1.5 Recent Development; 14.2 Eli Lilly And Company; 14.2.1 Company Snapshot; 14.2.2 Revenue Analysis; 14.2.3 Company Share Analysis; 14.2.4 Product Portfolio; 14.2.5 Recent Development/News; 14.3 Medtronic; 14.3.1 Company Snapshot; 14.3.2 Revenue Analysis; 14.3.3 Company Share Analysis; 14.3.4 Product Portfolio; 14.3.5 Recent Development; 14.4 Boston Scientific Corporation; 14.4.1 Company Snapshots; 14.4.2 Revenue Analysis And Segmented Analysis; 14.4.3 Company Share Analysis; 14.4.4 Product Portfolio; 14.4.5 Recent Development; 14.5 Johnson & Johnson Services, Inc.; 14.5.1 Company Snapshot; 14.5.2 Revenue Analysis; 14.5.3 Company Share Analysis; 14.5.4 Product Portfolio; 14.5.5 Recent Development/News; 14.6 Altimmune; 14.6.1 Company Snapshot; 14.6.2 Pipeline Portfolio; 14.6.3 Recent Updates; 14.7 Astrazeneca; 14.7.1 Company Snapshot; 14.7.2 Revenue Analysis; 14.7.3 Product Portfolio; 14.7.4 Recent Development/News; 14.8 Allurion; 14.8.1 Company Snapshot; 14.8.2 Revenue Analysis; 14.8.3 Product Portfolio; 1.1.5 Recent Development/News; 14.9 Amgen; 14.9.1 Company Snapshot; 14.9.2 Revenue Analysis; 14.9.3 Product Portfolio; 1.1.13 Recent Development/News; 14.10 Arena Pharmaceuticals Ltd; 14.10.1 Company Snapshot; 14.10.2 Product Portfolio; 14.10.3 Recent Development; 14.11 Currax Pharmaceuticals Llc; 14.11.1 Company Snapshot; 14.11.2 Product Portfolio; 14.11.3 Recent Development; 14.12 Cousin Surgery; 14.12.1 Company Snapshot; 14.12.2 Product Portfolio; 14.12.3 Recent Development; 14.13 F. Hoffmann-la Roche Ltd; 14.13.1 Company Snapshot; 14.13.2 Revenue Analysis; 14.13.3 Product Portfolio; 14.13.4 Recent Development/News; 14.14 Fitterfly Healthtech Pvt. Ltd.; 14.14.1 Company Snapshot; 14.14.2 Product Portfolio; 14.14.3 Recent Development; 14.15 Morphic Medical, Inc; 14.15.1 Company Snapshot; 14.15.2 Product Portfolio; 14.15.3 Recent Development; 14.16 Noom, Inc.; 14.16.1 Company Snapshot; 14.16.2 Product Portfolio; 14.16.3 Recent Development; 14.17 Omada Health Inc; 14.17.1 Company Snapshot; 14.17.2 Product Portfolio; 14.17.3 Recent Development; 14.18 Reshape Lifesciences; 14.18.1 Company Snapshot; 14.18.2 Revenue Analysis; 14.18.3 Product Portfolio; 1.1.7 Recent Development/News; 14.19 Raziel; 14.19.1 Company Snapshot; 14.19.2 Product Portfolio; 14.19.3 Recent Development; 14.20 Spatz Fgia Inc.; 14.20.1 Company Snapshot; 14.20.2 Product Portfolio; 14.20.3 Recent Development; 14.21 Sanofi; 14.21.1 Company Snapshot; 14.21.2 Revenue Analysis; 14.21.3 Product Portfolio; 14.21.4 Recent Development; 14.22 Saniona; 14.22.1 Company Snapshot; 14.22.2 Revenue Analysis; 14.22.3 Product Portfolio; 14.22.4 Recent Development; 14.23 Usgi Medical; 14.23.1 Company Snapshot; 14.23.2 Product Portfolio; 14.23.3 Recent Development; 14.24 Vivus Llc.; 14.24.1 Company Snapshot; 14.24.2 Product Portfolio; 14.24.3 Recent Development/News; 14.25 Viking Therapeutics; 14.25.1 Company Snapshots; 14.25.2 Revenue Analysis; 14.25.3 Product Portfolio; 14.25.4 Recent Development; 14.26 Zealand Pharma; 14.26.1 Company Snapshot; 14.26.2 Revenue Analysis; 14.26.3 Product Portfolio; 14.26.4 Recent Development/News
15 Questionnaire
16 Related Reports
List Of Tables: Table 1 Obesity Prevalence By Region (Adults); Table 2 Obesity Prevalence By Gender (Adults); Table 3 Obesity Prevalence By Age (Adults); Table 4 Middle East And Africa Clinical Trial Market For Obesity Treatment; Table 5 Distribution Of Products And Projects By Phase Middle East And Africa Obesity Treatment Market; Table 6 Distribution Of Projects By Therapeutic Area And Phase Middle East And Africa Obesity Treatment Market; Table 7 Middle East And Africa Obesity Statistics (2022); Table 8 Middle East And Africa Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 9 Middle East And Africa Pharmacological Treatments (Anti-obesity Drugs) In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 10 Middle East And Africa Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 11 Middle East And Africa Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 12 Middle East And Africa Bariatric Surgery In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 13 Middle East And Africa Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 14 Middle East And Africa Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 15 Middle East And Africa Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 16 Middle East And Africa Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 17 Middle East And Africa Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 18 Middle East And Africa Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 19 Middle East And Africa Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 20 Middle East And Africa Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 21 Middle East And Africa Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 22 Middle East And Africa Medical Devices & Technologies In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 23 Middle East And Africa Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 24 Middle East And Africa Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 25 Middle East And Africa Adult Obesity Treatment In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 26 Middle East And Africa Geriatric Obesity Treatment In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 27 Middle East And Africa Pediatric Obesity Treatment In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 28 Middle East And Africa Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 29 Middle East And Africa Online Pharmacies In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 30 Middle East And Africa Retail Pharmacies In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 31 Middle East And Africa Weight Management Clinics In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 32 Middle East And Africa Hospital Pharmacies In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 33 Middle East And Africa Wellness & Fitness Centers In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 34 Middle East And Africa Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 35 Middle East And Africa Class Iii In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 36 Middle East And Africa Class Ii In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 37 Middle East And Africa Class I In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 38 Middle East And Africa Obesity Treatment Market, By Country, 2018-2032 (Usd Thousand); Table 39 Middle East And Africa Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 40 Middle East And Africa Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 41 Middle East And Africa Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 42 Middle East And Africa Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 43 Middle East And Africa Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 44 Middle East And Africa Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 45 Middle East And Africa Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 46 Middle East And Africa Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 47 Middle East And Africa Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 48 Middle East And Africa Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 49 Middle East And Africa Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 50 Middle East And Africa Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 51 Middle East And Africa Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 52 Middle East And Africa Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 53 Saudi Arabia Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 54 Saudi Arabia Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 55 Saudi Arabia Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 56 Saudi Arabia Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 57 Saudi Arabia Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 58 Saudi Arabia Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 59 Saudi Arabia Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 60 Saudi Arabia Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 61 Saudi Arabia Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 62 Saudi Arabia Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 63 Saudi Arabia Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 64 Saudi Arabia Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 65 Saudi Arabia Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 66 Saudi Arabia Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 67 Egypt Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 68 Egypt Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 69 Egypt Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 70 Egypt Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 71 Egypt Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 72 Egypt Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 73 Egypt Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 74 Egypt Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 75 Egypt Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 76 Egypt Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 77 Egypt Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 78 Egypt Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 79 Egypt Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 80 Egypt Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 81 Kuwait Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 82 Kuwait Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 83 Kuwait Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 84 Kuwait Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 85 Kuwait Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 86 Kuwait Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 87 Kuwait Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 88 Kuwait Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 89 Kuwait Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 90 Kuwait Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 91 Kuwait Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 92 Kuwait Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 93 Kuwait Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 94 Kuwait Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 95 South Africa Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 96 South Africa Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 97 South Africa Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 98 South Africa Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 99 South Africa Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 100 South Africa Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 101 South Africa Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 102 South Africa Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 103 South Africa Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 104 South Africa Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 105 South Africa Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 106 South Africa Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 107 South Africa Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 108 South Africa Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 109 United Arab Emirates Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 110 United Arab Emirates Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 111 United Arab Emirates Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 112 United Arab Emirates Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 113 United Arab Emirates Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 114 United Arab Emirates Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 115 United Arab Emirates Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 116 United Arab Emirates Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 117 United Arab Emirates Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 118 United Arab Emirates Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 119 United Arab Emirates Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 120 United Arab Emirates Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 121 United Arab Emirates Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 122 United Arab Emirates Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 123 Israel Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 124 Israel Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 125 Israel Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 126 Israel Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 127 Israel Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 128 Israel Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 129 Israel Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 130 Israel Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 131 Israel Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 132 Israel Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 133 Israel Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 134 Israel Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 135 Israel Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 136 Israel Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 137 Rest Of Middle East And Africa Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand)
List Of Figures: Figure 1 North America Obesity Treatment Market: Segmentation; Figure 2 North America Obesity Treatment Market: Data Triangulation; Figure 3 North America Obesity Treatment Market: Droc Analysis; Figure 4 North America Obesity Treatment Market: Regional Market Analysis; Figure 5 North America Obesity Treatment Market: Company Research Analysis; Figure 6 North America Obesity Treatment Market: Lifeline Curve; Figure 7 North America Obesity Treatment Market: Interview Demographics; Figure 8 North America Obesity Treatment Market: Dbmr Market Position Grid; Figure 9 North America Obesity Treatment Market: Market End User Coverage Grid; Figure 10 North America Obesity Treatment Market: Vendor Share Analysis; Figure 11 North America Obesity Treatment Market: Segmentation; Figure 12 North America Obesity Treatment Market Executive Summary; Figure 13 Strategic Decisions; Figure 14 Five Segments Comprise The North America Obesity Treatment Market , By Treatment Type; Figure 15 Rising Prevalence Of Obesity Is Expected To Drive The Growth Of North America Obesity Treatment Market From 2025 To 2032; Figure 16 The Pharmacological Treatments (Anti-obesity Drugs) Segment Is Expected To Account For The Largest Share Of The North America Obesity Treatment Market In 2025 - 2032; Figure 17 Market Overview; Figure 18 Prevalence Of Obesity In Adults Age 20 And Older, By Sex And Age: United States, August 2021–august 2023 Source: Centers For Disease Control And Prevention.; Figure 19 Share Of Pre-obese And Obese Persons Aged 16 Years Or Over, By Sex, 2022 (%); Figure 20 North America Obesity Treatment Market: By Treatment Type, 2024; Figure 21 North America Obesity Treatment Market: By Treatment Type, 2025-2032 (Usd Thousand); Figure 22 North America Obesity Treatment Market: By Treatment Type, Cagr (2025-2032); Figure 23 North America Obesity Treatment Market: By Treatment Type, Lifeline Curve; Figure 24 North America Obesity Treatment Market: By Age Group, 2024; Figure 25 North America Obesity Treatment Market: By Age Group, 2025-2032 (Usd Thousand); Figure 26 North America Obesity Treatment Market: By Age Group, Cagr (2025-2032); Figure 27 North America Obesity Treatment Market: By Age Group, Lifeline Curve; Figure 28 North America Obesity Treatment Market: By Distribution Channel, 2024; Figure 29 North America Obesity Treatment Market: By Distribution Channel, 2025-2032 (Usd Thousand); Figure 30 North America Obesity Treatment Market: By Distribution Channel, Cagr (2025-2032); Figure 31 North America Obesity Treatment Market: By Distribution Channel, Lifeline Curve; Figure 32 North America Obesity Treatment Market: By Patient Type, 2024; Figure 33 North America Obesity Treatment Market: By Patient Type, 2025-2032 (Usd Thousand); Figure 34 North America Obesity Treatment Market: By Patient Type, Cagr (2025-2032); Figure 35 North America Obesity Treatment Market: By Patient Type, Lifeline Curve; Figure 36 North America Obesity Treatment Market: Snapshot (2024); Figure 37 North America Obesity Treatment Market: Company Share 2024 (%)

Pricing

Currency Rates

Single User Email from Publisher $3,500
Global Site License Email from Publisher $4,200

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now